Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.245 USD | -2.88% | +1.38% | -28.79% |
Mar. 27 | MiMedx Group Says FDA Affirms Axiofill Falls Short of Regulatory Standards for Tissue-Based Products | MT |
Mar. 27 | MiMedx Says FDA Still Won't Budge on Axiofill Designation, Files Lawsuit | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.79% | 922M | |
-20.09% | 129M | |
-16.12% | 61.39M | |
+7.05% | 60.85M | |
+0.60% | 51.57M |
- Stock Market
- Equities
- MDXG Stock
- News MiMedx Group, Inc.
- Transcript : MiMedx Group, Inc., Q2 2022 Earnings Call, Aug 03, 2022